These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 3023451)

  • 1. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
    J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.
    Tamura N; Agrawal DK; Townley RG
    J Immunol; 1988 Dec; 141(12):4291-7. PubMed ID: 2848892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
    Coëffier E; Joseph D; Vargaftig BB
    J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator.
    Erger RA; Casale TB
    Am J Respir Cell Mol Biol; 1995 Jan; 12(1):65-70. PubMed ID: 7811471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats.
    Martins MA; Etienne A; Soulard C; Domingo MT; Braquet P
    Braz J Med Biol Res; 1989; 22(9):1151-4. PubMed ID: 2636011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophils isolated by magnetic cell sorting respond poorly to lipid chemoattractants.
    Casale TB; Erger RA; Rozell MD
    Ann Allergy Asthma Immunol; 1999 Aug; 83(2):127-31. PubMed ID: 10480585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the expression of eosinophil IgE receptor (Fc epsilon R2) and its function by platelet-activating factor.
    Walsh GM; Moqbel R; Nagakura T; Iikura Y; Kay AB
    J Lipid Mediat; 1990; 2 Suppl():S177-86. PubMed ID: 1966815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
    Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
    J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects.
    Tamura N; Agrawal DK; Suliaman FA; Townley RG
    Biochem Biophys Res Commun; 1987 Feb; 142(3):638-44. PubMed ID: 3030295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.
    Iwamoto I; Tomoe S; Tomioka H; Yoshida S
    J Immunol; 1993 Aug; 151(4):2116-23. PubMed ID: 7688393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LTB4, a potent chemotactic factor for purified guinea-pig eosinophils: interference of PAF-acether antagonists.
    Coëffier E; Joseph D; Vargaftig BB
    Int J Immunopharmacol; 1991; 13(2-3):273-80. PubMed ID: 1649143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification on receptors for leukotriene B4 expressed on guinea-pig peritoneal eosinophils.
    Sehmi R; Rossi AG; Kay AB; Cromwell O
    Immunology; 1992 Sep; 77(1):129-35. PubMed ID: 1328044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils.
    Fukuda T; Numao T; Akutsu I; Makino S
    J Lipid Mediat; 1992; 5(2):145-9. PubMed ID: 1525356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of guinea pig eosinophil chemotactic factor of anaphylaxis as leukotriene B4 and 8(S),15(S)-dihydroxy-5,9,11,13(Z,E,Z,E)-eicosatetraenoic acid.
    Sehmi R; Cromwell O; Taylor GW; Kay AB
    J Immunol; 1991 Oct; 147(7):2276-83. PubMed ID: 1655889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate.
    el-Shazly AE; Masuyama K; Samejima Y; Eura M; Ishikawa T
    Immunopharmacol Immunotoxicol; 1996 Nov; 18(4):587-95. PubMed ID: 8933171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
    Takafuji S; Tadokoro K; Ito K; Nakagawa T
    Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptides modulate human eosinophil chemotaxis.
    Numao T; Agrawal DK
    J Immunol; 1992 Nov; 149(10):3309-15. PubMed ID: 1385521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RANTES is a chemotactic and activating factor for human eosinophils.
    Alam R; Stafford S; Forsythe P; Harrison R; Faubion D; Lett-Brown MA; Grant JA
    J Immunol; 1993 Apr; 150(8 Pt 1):3442-8. PubMed ID: 7682241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
    Goetzl EJ
    Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
    Casale TB; Erger RA; Little MM
    Am J Respir Cell Mol Biol; 1993 Jan; 8(1):77-82. PubMed ID: 8380250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.